Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | F2 | P00734 | 3/20 | 0.32 |
| ▸ | F10 | P00742 | 3/20 | 0.32 |
| ▸ | PLG | P00747 | 3/20 | 0.32 |
| ▸ | PLAT | P00750 | 3/20 | 0.32 |
| ▸ | PROC | P04070 | 3/20 | 0.32 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.32 |
| ▸ | MET | P08581 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL7457541 | 0.91 | F10 (0.33) | L3MBTL1F2F10PLGPLAT | |
| Trifluoroacetic Acid SCHEMBL7215785 | 0.91 | F10 (0.33) | L3MBTL1F2F10PLGPLAT | |
| Trifluoroacetic Acid SCHEMBL7453281 | 0.89 | HRH4 (0.34) | L3MBTL1F2F10PLGPLAT | |
| Trifluoroacetic Acid SCHEMBL7213617 | 0.89 | HRH4 (0.34) | L3MBTL1F2F10PLGPLAT | |
| Trifluoroacetic Acid SCHEMBL7213546 | 0.85 | F2 (0.34) | L3MBTL1F2F10PLGPLAT | |
| Trifluoroacetic Acid SCHEMBL7219220 | 0.85 | F2 (0.34) | L3MBTL1F2F10PLGPLAT | |
| SCHEMBL7453273 | 0.84 | MET (0.31) | MET | |
| SCHEMBL7214400 | 0.82 | F10 (0.40) | F2F10PLGPLATPROC | |
| SCHEMBL7448311 | 0.82 | F10 (0.40) | F2F10PLGPLATPROC | |
| Trifluoroacetic Acid SCHEMBL7446696 | 0.80 | KDR (0.35) | L3MBTL1F2F10PLGPLAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0944386-B1 | SULFONIC ACID OR SULFONYLAMINO N-(HETEROARALKYL)-AZAHETEROCYCLYLAMIDE COMPOUNDS | AVENTIS PHARMA INC (US) | 2002-09-18 | — | — | EP | claimed |
| US-6281227-B1 | INHIBITORS OF THE ACTIVITY OF FACTOR XA. | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-08-28 | — | — | US | claimed |
| US-6602864-B1 | Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-08-05 | — | — | US | disclosed |
| EP-0944386-B1 | SULFONIC ACID OR SULFONYLAMINO N-(HETEROARALKYL)-AZAHETEROCYCLYLAMIDE COMPOUNDS | AVENTIS PHARMA INC (US) | 2002-09-18 | — | — | EP | disclosed |
| US-6281227-B1 | INHIBITORS OF THE ACTIVITY OF FACTOR XA. | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-08-28 | — | — | US | disclosed |
| WO-2001039759-A2 | SULFONIC ACID OR SULFONYLAMINO N-(HETEROARALKYL)-AZAHETEROCYCLYLAMIDE COMPOUNDS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-06-07 | — | — | WO | disclosed |